An MRL/MpJ-<i>lpr/lpr</i> substrain with a limited expansion of <i>lpr</i> double-negative T cells and a reduced autoimmune syndromeLiliane Fossati, Shozo Izui, Jean‐Pierre Aubry et al.|International Immunology|1993Cited by 42
O07 Randomised, open labelled clinical trial to investigate synovial mechanisms determining response: resistance to rituximab versus tocilizumab in RA patients failing TNF inhibitor therapyFrances Humby, Costantino Pitzalis, Myles Lewis et al.|Lara D. Veeken|2020Cited by 2